1. CAS No.:910463-68-2
  2. Chemical formula: C187H291N45O59
  3. Molecular weight: 4113.57754

Detailed Description

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. 


Fields of application

Treatment of obesity

Treatment of type II diabetes mellitus